Westfield Capital Management CO LP Nkarta, Inc. Transaction History

Westfield Capital Management CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$12.79 - $26.88 $6.32 Million - $13.3 Million	-494,173 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$26.67 - $38.76 $525,692 - $763,998	19,711 Added 4.15%	494,173 $13.7 Million
Q2 2021 Aug 10, 2021	BUY	$23.94 - $36.68 $1.89 Million - $2.9 Million	78,958 Added 19.96%	474,462 $15 Million
Q1 2021 May 14, 2021	BUY	$31.33 - $59.61 $12.4 Million - $23.6 Million	395,504 New	395,504 $13 Million

126

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $121M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.